FIXX - Homology Medicines Inc
Close
0.601
-0.019 -3.161%
Share volume: 322,902
Last Updated: Mon 08 Jan 2024 10:00:00 PM CET
Pharmaceutical Preparation Manufacturing :
-2.88%
PREVIOUS CLOSE
CHG
CHG%
$0.62
-0.02
-3.07%
Fundamental analysis
22%
Profitability
0%
Dept financing
7%
Liquidity
75%
Performance
35%
Performance
5 Days
1.97%
1 Month
7.83%
3 Months
-44.14%
6 Months
-26.68%
1 Year
-60.76%
2 Year
-82.23%
Key data
Stock price
$0.60
DAY RANGE
N/A - N/A
52 WEEK RANGE
$0.46 - $1.76
52 WEEK CHANGE
-$0.61
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
03/07/2024
Company detail
CEO: Arthur Tzianabos
Region: US
Website: https://www.homologymedicines.com/
Employees: 131
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Pharmaceutical Preparation Manufacturing
Sector: Manufacturing
Region: US
Website: https://www.homologymedicines.com/
Employees: 131
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Pharmaceutical Preparation Manufacturing
Sector: Manufacturing
homology medicines is a genetic medicines company translating proprietary gene editing and gene therapy technologies into novel treatments for patients with rare diseases.
Recent news